Livedoid vasculopathy: Further evidence for procoagulant pathogenesis

Archives of Dermatology

Volumn 142, Issue 11, 2006, Pages 1413-1418

  Hairston, Bethany R ^a   Davis, Mark D P ^a   Pittelkow, Mark R ^a   Ahmed, Iftikhar ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LABORATORY TEST; LEG DISEASE; LIVEDO RETICULARIS; LIVEDOID VASCULOPATHY; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; THROMBOSIS; ULCER; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; CHILD; FEMALE; FOOT DERMATOSES; HUMANS; LEG ULCER; MALE; MEDICAL RECORDS; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, VASCULAR;

EID: 33751250798     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.11.1413     Document Type: Article

References (51)

1. Bard JW, Winkelmann RK. Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol. 1967;96:489-499.
2. Milian G. Les atrophies cutanées syphilitiques. Bull Soc Franc Derm Syph. 1929;36:865-871.
3. Feldaker M, Hines EA Jr, Kierland RR. Livedo reticularis with ulcerations. Circulation. 1956;13:196-216.
4. Winkelmann RK, Schroeter AL, Kierland RR, Ryan TM. Clinical studies of livedoid vasculitis (segmental hyalinizing vasculitis). Mayo Clin Proc. 1974;49:746-750.
5. Shornick JK, Nicholes BK, Bergstresser PR, Gilliam JN. Idiopathic atrophie blanche. J Am Acad Dermatol. 1983;8:792-798.
6. Stevanovic DV. Atrophie blanche: a sign of dermal blood occlusion. Arch Dermatol. 1974;109:858-862.
7. Pizzo SV, Murray JC, Gonias SL. Atrophie blanche: a disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med. 1986;110:517-519.
8. McCalmont CS, McCalmont TH, Jorizzo JL, White WL, Leshin B, Rothberger H. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol. 1992;17:4-8.
9. Hegemann B, Helmbold P, Marsch WC. Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. Arch Dermatol. 2002;138:841-842.
10. Rooke TW. The noninvasive vascular laboratory. Cardiovasc Clin. 1992;22:27-44.
11. Rooke TW, Heser JL, Osmundson PJ. Exercise strain-gauge venous plethysmography: evaluation of a "new" device for assessing lower limb venous incompetence. Angiology. 1992;43:219-228.
12. Rooke TW. The use of transcutaneous oximetry in the noninvasive vascular laboratory. Int Angiol. 1992;11:36-40.
13. Gray HR, Graham JH, Johnson W, Burgoon CF Jr. Atrophie blanche: periodic painful ulcers of lower extremities: a clinical and histopathogical entity. Arch Dermatol. 1966;93:187-193.
14. Nelson LM. Atrophie blanche en plaque. Arch Dermatol. 1955;72:242-251.
15. Chen KR, Toyohara A, Suzuki A, Miyakawa S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol. 2002;147:905-913.
16. Mimouni D, Ng PP, Rencic A, Nikolskaia OV, Bernstein BD, Nousari HC. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol. 2003;148:789-794.
17. Yasue T. Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Arch Dermatol. 1986;122:66-70.
18. Alegre VA, Gastineau DA, Winkelmann RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol. 1989;120:419-429.
19. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 1981;60:288-297.
20. Vanness ER, Davis MD, Tefferi A. Cutaneous findings associated with chronic natural killer cell lymphocytosis. Int J Dermatol. 2002;41:852-857.
21. Jorizzo JL. Livedoid vasculopathy: what is it? Arch Dermatol. 1998;134:491-493.
22. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
23. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol. 1997;34:171-187.
24. Lee DH, Henderson PA, Blajchman MA. Prevalence of factor V Leiden in a Canadian blood donor population. CMAJ. 1996;155:285-289.
25. Salomon O, Steinberg DM, Zivelin A, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol. 1999;19:511-518.
26. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. JAMA. 1997;277:1305-1307.
27. Biedermann T, Flaig MJ, Sander CA. Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol. 2000;27:410-412.
28. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol. 2002;46:133-137.
29. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
30. Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706-708.
31. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 1995;73:87-93.
32. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost. 1988;59:18-22.
33. Pabinger I, Brücker S, Kyrle PA, et al. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinolysis. 1992;3:547-553.
34. Baccard M, Vignon-Pennamen MD, Janier M, Scrobohaci ML, Dubertret L. Livedo vasculitis with protein C system deficiency. Arch Dermatol. 1992;128:1410-1411.
35. Boyvat A, Kundakci N, Babikir MO, Gurgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol. 2000;143:840-842.
36. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81:165-176.
37. Ray JG. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998;158:2101-2106.
38. Gibson GE, Li H, Pittelkow MR. Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol. 1999;40:279-281.
39. Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med. 1980;92:156-159.
40. Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol. 1990;76:101-107.
41. Murano G. The "Hageman" connection: interrelationships of blood coagulation, fibrinogenolysis, kinin generation, and complement activation. Przegl Lek. 1981;38:709-713.
42. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol. 1999;140:131-135.
43. Grob JJ, Bonerandi JJ. Thrombotic skin disease as a marker of the anticardiolipin syndrome: livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J Am Acad Dermatol. 1989;20:1063-1069.
44. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.Aust N Z J Med. 1990;20:231-236.
45. Fields RA, Toubbeh H, Searles RP, Bankhurst AD. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol. 1989;16:623-625.
46. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987;69:557-565.
47. Combemale P, Amiral J, Estival JL, Dupin M, Chouvet B, Berruyer M. Cutaneous necrosis revealing the coexistence of an antiphospholipid syndrome with acquired protein S deficiency, factor V Leiden and hyperhomocysteinemia. Eur J Dermatol. 2002;12:278-282.
48. Schroeter AL, Diaz-Perez JL, Winkelmann RK, Jordan RE. Livedo vasculitis (the vasculitis of atrophie blanche): immunohistopathologic study. Arch Dermatol. 1975;111:188-193.
49. Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med. 2002;195:211-220.
50. Salmon JE, Girardi G, Holers VM. Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis. 2002;61(suppl 2):ii46-ii50.
51. Tran MD, Becherel PA, Cordel N, Piette JC, Frances C. "Idiopathic" white atrophy [in French]. Ann Dermatol Venereol. 2001;128:1003-1007.